Nektar Therapeutics will make “significant adjustments” to its operations in the coming weeks as a result of “extremely disturbing” results indicating the medicine bempegaldesleukin failed…
Nektar Therapeutics will make “significant adjustments” to its operations in the coming weeks as a result of “extremely disturbing” results indicating the medicine bempegaldesleukin failed…